Fremanezumab Prefilled Syringe [Ajovy]
2020P-001191
Approved small_molecule terminated
Quick answer
Fremanezumab Prefilled Syringe [Ajovy] for Migraine Disorders is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Migraine Disorders
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated